Close
Close
Treatment Database
antisense oligonucleotide specific to the antisense transcript of UBE3A
Trade Name not avaiable
Orphan Indication Angelman Syndrome
USA Market Approval
USA Designation Date 15-03-2018
Sponsor GeneTx Biotherapeutics, LLC
1918 Sweetbriar Lane
Darien, Illinois, 60561
More about Angelman syndrome
Free Newsletter
Related Videos